| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*
Department of Cellular and Molecular Medicine, University of Ottawa,
Ottawa, Ontario, Canada.
Department of Medicine, University of Ottawa, Ottawa, Ontario,
Canada.
Department of Biochemistry, Microbiology and Immunology, University of
Ottawa, Ottawa, Ontario, Canada.
Correspondence to Dr. Odette Laneuville, Department of Biochemistry, Microbiology, and Immunology, 451 Smyth Road, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5. Phone: 613-562-5800, extension 8402; Fax: 613-562-5440; E-mail: olaneuv{at}danis.med.uottawa.ca
Abstract. The cortical collecting duct (CCD) is a major site of intrarenal prostaglandin E2 (PGE2) synthesis. This study examines the expression and regulation of the prostaglandin synthesizing enzymes cyclooxygenase-1 (COX-1) and -2 in the CCD. By indirect immunofluorescence using isoform-specific antibodies, COX-1 and -2 immunoreactivity was localized to all cell types of the murine M-1 CCD cell line. By immunohistochemistry, both COX-1 and COX-2 were localized to intercalated cells of the CCD on paraffin-embedded mouse kidney sections. When COX enzyme activity was measured in the M-1 cells, both indomethacin (COX-1 and -2 inhibitor) and the specific COX-2 inhibitor NS-398 effectively blocked PGE2 synthesis. These results demonstrate that COX-2 is the major contributor to the pool of PGE2 synthesized by the CCD. By Western blot analysis, COX-2 expression was significantly upregulated by incubation with either indomethacin or NS-398. These drugs did not affect COX-1 protein expression. Evaluation of COX-2 mRNA expression by Northern blot analysis after NS-398 treatment demonstrated that the COX-2 protein upregulation occurred independently of any change in COX-2 mRNA expression. These studies have for the first time localized COX-2 to the CCD and provided evidence that the intercalated cells of the CCD express both COX-1 and COX-2. The results also demonstrate that constitutively expressed COX-2 is the major COX isoform contributing to PGE2 synthesis by the M-1 CCD cell line. Inhibition of COX-2 activity in the M-1 cell line results in an upregulation of COX-2 protein expression.
This article has been cited by other articles:
![]() |
G.-H. Kim, N. W. Choi, J.-Y. Jung, J.-H. Song, C. H. Lee, C. M. Kang, and M. A. Knepper Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2 Am J Physiol Renal Physiol, April 1, 2008; 294(4): F702 - F709. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sankaran, N. Bankovic-Calic, M. R. Ogborn, G. Crow, and H. M. Aukema Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease Am J Physiol Renal Physiol, September 1, 2007; 293(3): F821 - F830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Opay, C. R. Mouton, J. J. Mullins, and K. D. Mitchell Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, September 1, 2006; 291(3): F612 - F618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Harris and M. D. Breyer Update on Cyclooxygenase-2 Inhibitors Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 236 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yang, A. Zhang, M. Honeggar, D. E. Kohan, D. Mizel, K. Sanders, J. R. Hoidal, J. P. Briggs, and J. B. Schnermann Hypertonic Induction of COX-2 in Collecting Duct Cells by Reactive Oxygen Species of Mitochondrial Origin J. Biol. Chem., October 14, 2005; 280(41): 34966 - 34973. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nasrallah and R. L. Hebert Prostacyclin signaling in the kidney: implications for health and disease Am J Physiol Renal Physiol, August 1, 2005; 289(2): F235 - F246. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nasrallah, A. Landry, S. Singh, M. Sklepowicz, and R. L. Hebert Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1068 - F1077. [Abstract] [Full Text] |
||||
![]() |
A. L. Fuson, P. Komlosi, T. M. Unlap, P. D. Bell, and J. Peti-Peterdi Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney Am J Physiol Renal Physiol, September 1, 2003; 285(3): F558 - F564. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, W. Tian, C. Tai, and D. M. Cohen Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR Am J Physiol Renal Physiol, August 1, 2003; 285(2): F281 - F288. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Campean, F. Theilig, A. Paliege, M. Breyer, and S. Bachmann Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse) Am J Physiol Renal Physiol, July 1, 2003; 285(1): F19 - F32. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyataka, K. A. Rich, M. Ingram, T. Yamamoto, and R. J. Bing Nitric Oxide, Anti-Inflammatory Drugs on Renal Prostaglandins and Cyclooxygenase-2 Hypertension, March 1, 2002; 39(3): 785 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bing and M. Lomnicka Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events? J. Am. Coll. Cardiol., February 6, 2002; 39(3): 521 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ostrom, C. Gregorian, R. M. Drenan, K. Gabot, B. K. Rana, and P. A. Insel Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP Am J Physiol Cell Physiol, August 1, 2001; 281(2): C524 - C531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Harris and M. D. Breyer Physiological regulation of cyclooxygenase-2 in the kidney Am J Physiol Renal Physiol, July 1, 2001; 281(1): F1 - F11. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nasrallah, O. Laneuville, S. Ferguson, and R. L. Hebert Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells Am J Physiol Renal Physiol, July 1, 2001; 281(1): F123 - F132. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Abassi, S. Brodsky, O. Gealekman, I. Rubinstein, A. Hoffman, and J. Winaver Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure Am J Physiol Renal Physiol, January 1, 2001; 280(1): F43 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. HARRIS Cyclooxygenase-2 in the Kidney J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2387 - 2394. [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673